Stock vs Stock Comparison

Johnson & Johnson vs Absci Corporation

JNJ wins the Tale of the Tape 7–2.

JNJ$222.89
ABSI$6.35

🏆 Tale of the Tape

72
JNJABSI
28.5%Profitability (Net Margin)-4113.7%
26.1xValuation (P/E)
18.3%Efficiency (ROIC)-46.9%
4/9Health (Piotroski F)2/9
4.0Safety (Altman Z)5.1
6.0%Growth (Rev YoY)-38.2%
2.69Risk (Sharpe 1Y)0.56
1.44xBalance Sheet (D/E)0.14x
3.25%FCF Yield-21.57%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.095
252-Day Correlation
-0.008
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricJNJABSI
Market Cap$542.4B$1.1B
P/E Ratio26.1x
Forward P/E17.7x-10.6x
P/B6.68x6.10x
Dividend Yield2.38%
Beta0.262.38

Quantitative Metrics

MetricJNJABSI
DCF Fair Value$134.24
DCF Upside-43.6%
Piotroski F4/92/9
Altman Z3.975.11
Beneish M-2.27
FCF Yield3.25%-21.57%
Net Debt/EBITDA0.5x
ROIC18.3%-46.9%
WACC7.7%
ROIC – WACC10.5pp
Gross Margin67.9%
Net Margin28.5%-4113.7%
Rev Growth YoY6.0%-38.2%
Sharpe (1Y)2.690.56
Max Drawdown 3Y-16.0%-66.1%
FCF Payout Ratio64%

JNJ Price

Loading chart...

ABSI Price

Loading chart...

ETF Exposure

JNJ found in:

XLV10.42%
IYH10.14%
VHT8.84%
HDV6.84%
MTUM3.76%
DIA2.83%
MGV2.75%
DGRO2.64%
VIG2.49%
VYM2.30%
VTV2.16%
DGRW2.02%
SCHV2.02%
IWD1.94%
QUS1.81%
XPH1.74%
VONV1.69%
NOBL1.58%
VFMV1.42%
VFMO1.02%
SCHX0.96%
SPYG0.94%
SDY0.93%
VOO0.90%
SCHB0.90%
SPY0.87%
IVV0.85%
VONE0.84%
SPTM0.81%
VTI0.80%
SPYV0.79%
SPLG0.76%
ITOT0.75%
URTH0.70%
ACWI0.57%
VT0.49%
RSP0.21%
VFVA0.15%
ONEO0.05%

ABSI found in:

ARKG4.81%
XBI0.32%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

JNJ vs ABSI: Head-to-Head Analysis

Johnson & Johnson (JNJ) and Absci Corporation (ABSI) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, JNJ leads 7–2 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, JNJ generates a return on invested capital (ROIC) of 18.3% compared to ABSI's -46.9%. This suggests JNJ is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between JNJ and ABSI is 0.095, indicating low correlation, making them an effective diversification pair in a portfolio context.

JNJ appears in 39 ETFs tracked by SecuritiesDB, while ABSI appears in 2 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, JNJ or ABSI?

Our quantitative analysis compares JNJ and ABSI across nine fundamental dimensions. JNJ wins the Tale of the Tape 7–2. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are JNJ and ABSI correlated?

The 252-day correlation between JNJ and ABSI is 0.095. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.